Search

Search Constraints

You searched for: Author/Creator Bansi-Matharu, Loveleen

Search Results

11. Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa. Issue 7 (July 2022)

12. Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile. (29th July 2016)

13. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Issue 9 (September 2020)

14. Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance. (18th December 2019)

15. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Issue 4 (April 2023)

16. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV. (1st March 2023)

17. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Issue 2 (February 2019)

18. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure. (1st August 2019)

19. Sociodemographic differences in symptom severity and duration among women referred to secondary care for menorrhagia in England and Wales: a cohort study from the National Heavy Menstrual Bleeding Audit. Issue 2 (2nd February 2018)

20. The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis. Issue 5 (May 2021)